Engerix-B: all 29 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCDRecruitingNCT05200338Not applicable
- Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix-BCompletedNCT02901951Phase 4Results posted
- Hepatitis B Vaccine in Chronic Hepatitis B Patients With Low Serum HBsAgCompletedNCT01817725Phase 1Results posted
- Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African InfantsCompletedNCT01231503Phase 2Results posted
- Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated ChildrenCompletedNCT01138098Phase 4Results posted
- Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix AdultCompletedNCT01037114Phase 4Results posted
- Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix AdultCompletedNCT01000324Phase 4Results posted
- Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B VaccineCompletedNCT00657657Phase 4Results posted
- Challenge Dose of Hepatitis B Vaccine in Subjects Who Previously Received Engerix™-B VaccineCompletedNCT00524576Phase 4Results posted
- Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.CompletedNCT00456625Phase 4Results posted
- Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 YrsCompletedNCT00343915Phase 3Results posted
- Follow-up Study 16-20 Years After Primary Vaccination Against Hepatitis B of Newborns From HBeAg+ & HBsAg+ MothersCompletedNCT00240500Phase 4Results posted
- Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive YouthCompletedNCT00106964Phase 4Results posted
- Demonstration Project on Health Care Worker Protection Against Hepatitis B in Kalulushi DistrictCompletedNCT04072211Phase 4
- Hepatitis B Virus Vaccination in HIV-positive Patients and Individuals at High Risk for HIV InfectionStatus unknownNCT03854630Phase 4
- HBsAb Response After HBV Vaccination in Chronic Hepatitis B Patients Who Have Lost HBsAgStatus unknownNCT03405597Phase 3
- Efficacy of HBV Vaccine in Consolidation of Nucleos(t)Ide Analogues TherapyCompletedNCT02505009Phase 4
- A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination CoursesCompletedNCT02434848Phase 2/3
- Hepatitis B Vaccine in Patients With Inflammatory Bowel DiseaseCompletedNCT01531075Not applicable
- Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) VaccinationTerminatedNCT01082861Phase 4
- Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy AdolescentsCompletedNCT00697775Phase 2
- Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different SchedulesCompletedNCT00697229Phase 2
- A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXACompletedNCT00693186Phase 3
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNCT00383591Phase 3
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNCT00383383Phase 3
- Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis PatientsCompletedNCT00186836Phase 4
- Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster InjectionsCompletedNCT00169858Phase 4
- Immunologic Memory (Supp. of ATN 024)CompletedNCT00142753Phase 4
- Does Extra-High Dose Hepatitis B Vaccination Confer Longer Serological Protection in Peritoneal Dialysis Patients?CompletedNCT00125775Phase 4